tirzepatide nafld glp 1 liver disease glp-1 fatty Multiple target tissue effects of analogues on non-alcoholic (NAFLD) and non-alcoholic steatohepatitis (NASH) The Emerging Role of Glucagon-Like – Effects of GLP-1 receptor agonists – Synergistic mechanisms of tirzepatide and

10:30 - Shawn gets into the biochemistry of caffeine - 1,3,7-trimethylxanthine When you metabolize it -- de-methylate it -- you end up with three other di -methylxanthines

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice

The fix is not complicated, but it requires intentional effort

The author holds equity interest in RNA Therapeutics Inc, DEI Biopharma Inc, Abyolo, and BioRx Inc, but none of these create any conflict of interest for this paper

Whether any of that holds is a question about evidence, and the evidence is genuinely contradictory rather than merely thin